HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ellie He Selected Research

Hydrocodone (Dihydrocodeinone)

1/2018Effectiveness and Safety of Once-Daily Extended-Release Hydrocodone in Individuals Previously Receiving Immediate-Release Oxycodone for Chronic Pain.
11/2017Safety and effectiveness of once-daily Hysingla extended-release tablets in patients with baseline depression or anxiety.
1/2017Evaluation of the Ototoxicity Potential of Once-Daily, Single-Entity Hydrocodone in Patients with Chronic Pain: Results of Two Phase-3 Clinical Studies.
1/2017Efficacy and Safety of Once-Daily Extended-Release (ER) Hydrocodone in Individuals Previously Receiving ER Morphine for Chronic Pain.
1/2017Hysingla® ER, a once-daily, single-entity hydrocodone with abuse-deterrent properties in treating chronic nonmalignant and nonneuropathic pain in patients with osteoarthritis.
1/2017Long-term effectiveness and safety of once-daily, single-entity, extended-release hydrocodone in patients of ≥75 years of age with moderate to severe nonmalignant and nonneuropathic pain.
1/2016Long-term safety and effectiveness of once-daily, single-entity, extended-release hydrocodone over 76 weeks of an open-label study in patients with chronic noncancer and nonneuropathic pain.
11/2015Pain intensity and interference with functioning and well-being in subgroups of patients with chronic pain treated with once-daily hydrocodone tablets.
7/201512-Month safety and effectiveness of once-daily hydrocodone tablets formulated with abuse-deterrent properties in patients with moderate to severe chronic pain.
1/2015A multicenter, randomized, double-blind, placebo-controlled trial to assess the efficacy and safety of single-entity, once-daily hydrocodone tablets in patients with uncontrolled moderate to severe chronic low back pain.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ellie He Research Topics

Disease

9Chronic Pain
01/2018 - 01/2015
9Pain (Aches)
01/2018 - 01/2015
2Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder)
11/2021 - 01/2021
2Neuralgia (Stump Neuralgia)
01/2018 - 11/2015
2Constipation
01/2018 - 07/2015
2Vomiting
01/2018 - 07/2015
2Dizziness (Lightheadedness)
01/2018 - 07/2015
2Nausea
01/2018 - 07/2015
2Cystic Fibrosis (Mucoviscidosis)
03/2014 - 01/2011
1Sleep Initiation and Maintenance Disorders (Insomnia)
01/2021
1Ototoxicity
01/2017
1Deafness (Deaf Mutism)
01/2017
1Sensorineural Hearing Loss
01/2017
1Osteoarthritis
01/2017
1Sleepiness
07/2015
1Fatigue
07/2015
1Headache (Headaches)
07/2015
1Low Back Pain (Lumbago)
01/2015
1Cough
01/2011
1Pseudomonas Infections
01/2011

Drug/Important Bio-Agent (IBA)

11Hydrocodone (Dihydrocodeinone)FDA LinkGeneric
01/2018 - 01/2015
9Opioid Analgesics (Opioids)IBA
01/2018 - 01/2015
6TabletsIBA
01/2017 - 01/2015
3Analgesics (Analgesic Drugs)IBA
01/2018 - 01/2015
2Methylphenidate (Ritalin)FDA LinkGeneric
11/2021 - 01/2021
2Delayed-Action PreparationsIBA
11/2017 - 01/2017
2Acetaminophen (Paracetamol)FDA LinkGeneric
01/2017 - 01/2015
2SolutionsIBA
03/2014 - 01/2011
2PowdersIBA
03/2014 - 01/2011
2Pharmaceutical PreparationsIBA
03/2014 - 01/2011
2Tobramycin (Nebcin)FDA LinkGeneric
03/2014 - 01/2011
1Oxycodone (Oxycontin)FDA LinkGeneric
01/2018
1Morphine (MS Contin)FDA LinkGeneric
01/2017

Therapy/Procedure

4Analgesia
01/2018 - 01/2015
1Pain Management
01/2017
1Activities of Daily Living (ADL)
07/2015
1Therapeutics
01/2015